Skip to main content

Table 2 Distribution of persistenta and clearedb high-risk (hr) human papillomavirus (HPV) infections in 71 included WLWH

From: Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark – the SHADE

 

HrHPV infections, n(% of total number of WLWH) (n = 112)

HrHPV persistence, n(%)

HrHPV clearance, n(%)

hrHPV16

12 (10.7)

4 (33.3)

8 (66.7)

hrHPV18

5 (4.4)

0 (0)

5 (100.0)

hrHPV31

10 (8.9)

4 (40.0)

6 (60.0)

hrHPV33

7 (6.3)

3 (42.9)

4 (57.1)

hrHPV35

13 (11.6)

5 (38.5)

8 (61.5)

hrHPV39

4 (3.6)

0 (0)

4 (100.0)

hrHPV45

3 (2.7)

1 (33.3)

2 (66.7)

hrHPV51

13 (11.6)

4 (30.8)

9 (69.2)

hrHPV52

14 (12.5)

11 (78.6)

3 (21.4)

hrHPV56

5 (4.4)

1 (20.0)

4 (80.0)

hrHPV58

20 (17.9)

5 (25.0)

15 (75.0)

hrHPV59

0 (0)

0 (0)

0 (0)

hrHPV68

6 (5.4)

0 (0)

6 (100.0)

  1. WLWH = women living with HIV
  2. aPersistent = Type-specific persistence was defined as positivity of the same hrHPV type in two separate cervical samples having been taken at least 1 year and at most 2 years after the date the patient was first hrHPV positive, bCleared = having one or more negative results after an hrHPV positive sample